Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS buprenorphine practice guidelines /

Bibliographic Details
Corporate Author:	United States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation (Author)
Format:	Government Document eBook
Language:	English
Published:	[Washington, D.C.] : U.S. Department of Health and Human Services, 2022.
Subjects:	Drug abuse > Prevention. Drugs > Overdose. Opioid abuse. Buprenorphine. Time-series analysis.
Online Access:	https://purl.fdlp.gov/GPO/gpo213242

Available Online